227 related articles for article (PubMed ID: 28358601)
1. Pharmacogenetics in the treatment of pre-eclampsia: current findings, challenges and perspectives.
Luizon MR; Palei AC; Cavalli RC; Sandrim VC
Pharmacogenomics; 2017 Apr; 18(6):571-583. PubMed ID: 28358601
[TBL] [Abstract][Full Text] [Related]
2. Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy.
Luizon MR; Palei ACT; Belo VA; Amaral LM; Lacchini R; Duarte G; Cavalli RC; Sandrim VC; Tanus-Santos JE
Pharmacogenomics J; 2017 Oct; 17(5):427-434. PubMed ID: 27168100
[TBL] [Abstract][Full Text] [Related]
3. eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestational hypertension.
Sandrim VC; Palei AC; Luizon MR; Izidoro-Toledo TC; Cavalli RC; Tanus-Santos JE
Pharmacogenomics J; 2010 Feb; 10(1):40-5. PubMed ID: 19704415
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomics of Preeclampsia therapies: Current evidence and future challenges for clinical implementation.
Chaemsaithong P; Biswas M; Lertrut W; Warintaksa P; Wataganara T; Poon LC; Sukasem C
Best Pract Res Clin Obstet Gynaecol; 2024 Feb; 92():102437. PubMed ID: 38103508
[TBL] [Abstract][Full Text] [Related]
5. Effects of matrix metalloproteinase (MMP)-2 polymorphisms on responsiveness to antihypertensive therapy of women with hypertensive disorders of pregnancy.
Palei AC; Sandrim VC; Amaral LM; Machado JS; Cavalli RC; Lacchini R; Duarte G; Tanus-Santos JE
Basic Clin Pharmacol Toxicol; 2012 Oct; 111(4):262-7. PubMed ID: 22672240
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive therapy in pre-eclampsia: effects of plasma from nonresponsive patients on endothelial gene expression.
Luizon MR; Caldeira-Dias M; Deffune E; Fernandes KS; Cavalli RC; Tanus-Santos JE; Sandrim VC
Pharmacogenomics; 2016 Jul; 17(10):1121-1127. PubMed ID: 27348131
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomic approaches that may guide preeclampsia therapy.
Luizon MR; Sandrim VC
Pharmacogenomics; 2013 Apr; 14(6):591-3. PubMed ID: 23570460
[No Abstract] [Full Text] [Related]
8. [Management of severe pre-eclampsia/eclampsia. Comparison between nifedipine and hydralazine as antihypertensive agents].
Walss Rodriguez RJ; Flores Padilla LM
Ginecol Obstet Mex; 1993 Mar; 61():76-9. PubMed ID: 8454221
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy.
Palei AC; Sandrim VC; Amaral LM; Machado JS; Cavalli RC; Lacchini R; Duarte G; Tanus-Santos JE
Pharmacogenomics J; 2012 Dec; 12(6):489-98. PubMed ID: 21769110
[TBL] [Abstract][Full Text] [Related]
10. [General treatment principles and antihypertensive therapy in pregnancy-induced hypertension, pre-eclampsia and eclampsia].
Lechner W
Gynakol Rundsch; 1991; 31(4):233-5. PubMed ID: 1794725
[No Abstract] [Full Text] [Related]
11.
Luizon MR; Pinto-Souza CC; Coeli-Lacchini F; Lacchini R; Cavalli RC; Sandrim VC
Pharmacogenomics; 2022 Aug; 23(13):713-722. PubMed ID: 35971863
[No Abstract] [Full Text] [Related]
12. Pharmacogenomic approaches to study the effects of antihypertensive drugs.
Kamide K; Kawano Y; Rakugi H
Hypertens Res; 2012 Aug; 35(8):796-9. PubMed ID: 22739423
[TBL] [Abstract][Full Text] [Related]
13. [Antihypertensive treatment in pregnancy].
Souza AR; Amorim MR; Costa AA; Neto CN
Acta Med Port; 2010; 23(1):77-84. PubMed ID: 20353709
[TBL] [Abstract][Full Text] [Related]
14. [Methyldopa in therapy of hypertension in pregnant women].
Seremak-Mrozikiewicz A; Drews K
Ginekol Pol; 2004 Feb; 75(2):160-5. PubMed ID: 15108591
[TBL] [Abstract][Full Text] [Related]
15. Severe pre-eclampsia and hypertensive crises.
Arulkumaran N; Lightstone L
Best Pract Res Clin Obstet Gynaecol; 2013 Dec; 27(6):877-84. PubMed ID: 23962474
[TBL] [Abstract][Full Text] [Related]
16. Different profiles of circulating arginase 2 in subtypes of preeclampsia pregnant women.
Bertozzi-Matheus M; Bueno-Pereira TO; Viana-Mattioli S; Carlström M; Cavalli RC; Sandrim VC
Clin Biochem; 2021 Jun; 92():25-33. PubMed ID: 33713637
[TBL] [Abstract][Full Text] [Related]
17. [Pros and cons in the therapy of hypertensive gestoses. I. Pre-eclampsia and eclampsia].
Kyank H; During R
Zentralbl Gynakol; 1978; 100(22):1465-71. PubMed ID: 746988
[TBL] [Abstract][Full Text] [Related]
18. Interaction Between NOS3 and HMOX1 on Antihypertensive Drug Responsiveness in Preeclampsia.
Sandrim VC; Luizon MR; Pilan E; Caldeira-Dias M; Coeli-Lacchini FB; Kors G; Berndt I; Lacchini R; Cavalli RC
Rev Bras Ginecol Obstet; 2020 Aug; 42(8):460-467. PubMed ID: 32559798
[TBL] [Abstract][Full Text] [Related]
19. Hypertension in pregnancy: current concepts of preeclampsia.
Witlin AG; Sibai BM
Annu Rev Med; 1997; 48():115-27. PubMed ID: 9046950
[TBL] [Abstract][Full Text] [Related]
20. The treatment of hypertension in pregnancy.
Michael CA
Aust Fam Physician; 1978 Sep; 7(9):1113-7. PubMed ID: 736851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
